A detailed history of Los Angeles Capital Management LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 62,062 shares of EXAS stock, worth $3.48 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
62,062
Holding current value
$3.48 Million
% of portfolio
0.02%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$42.43 - $70.83 $2.63 Million - $4.4 Million
62,062 New
62,062 $4.23 Million
Q1 2024

Apr 05, 2024

SELL
$56.27 - $73.77 $614,918 - $806,158
-10,928 Reduced 60.24%
7,214 $498,000
Q4 2023

Feb 06, 2024

BUY
$59.06 - $75.72 $1.07 Million - $1.37 Million
18,142 New
18,142 $1.34 Million
Q1 2023

May 04, 2023

BUY
$47.19 - $70.77 $266,151 - $399,142
5,640 New
5,640 $382,000
Q2 2021

Aug 05, 2021

SELL
$93.66 - $139.27 $192,939 - $286,896
-2,060 Reduced 52.03%
1,899 $236,000
Q1 2021

May 05, 2021

SELL
$116.57 - $155.01 $321,033 - $426,897
-2,754 Reduced 41.02%
3,959 $521,000
Q4 2020

Feb 04, 2021

BUY
$99.61 - $142.12 $357,799 - $510,495
3,592 Added 115.09%
6,713 $889,000
Q3 2020

Nov 02, 2020

BUY
$72.92 - $102.01 $227,583 - $318,373
3,121 New
3,121 $318,000
Q2 2020

Aug 05, 2020

SELL
$55.75 - $92.75 $904,265 - $1.5 Million
-16,220 Closed
0 $0
Q4 2019

Feb 07, 2020

BUY
$77.66 - $99.74 $957,936 - $1.23 Million
12,335 Added 317.5%
16,220 $1.5 Million
Q3 2019

Nov 07, 2019

SELL
$90.37 - $122.49 $24,399 - $33,072
-270 Reduced 6.5%
3,885 $351,000
Q2 2019

Jul 29, 2019

SELL
$89.51 - $118.04 $4.6 Million - $6.07 Million
-51,402 Reduced 92.52%
4,155 $490,000
Q1 2019

Apr 25, 2019

BUY
$61.98 - $96.5 $3.13 Million - $4.87 Million
50,470 Added 992.14%
55,557 $4.81 Million
Q4 2018

Feb 11, 2019

SELL
$56.04 - $82.66 $11,768 - $17,358
-210 Reduced 3.96%
5,087 $321,000
Q3 2018

Nov 05, 2018

SELL
$48.29 - $80.6 $1.4 Million - $2.34 Million
-29,065 Reduced 84.58%
5,297 $418,000
Q2 2018

Jul 31, 2018

SELL
$37.84 - $69.96 $1.7 Million - $3.14 Million
-44,820 Reduced 56.6%
34,362 $2.06 Million
Q1 2018

Apr 27, 2018

BUY
$39.82 - $57.53 $121,052 - $174,891
3,040 Added 3.99%
79,182 $3.19 Million
Q4 2017

Feb 05, 2018

BUY
$46.49 - $60.51 $2.64 Million - $3.44 Million
56,887 Added 295.44%
76,142 $4 Million
Q3 2017

Nov 06, 2017

BUY
$37.05 - $47.12 $713,397 - $907,295
19,255
19,255 $907,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.93B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.